Lantern Pharma Announces Public Release of AI Module for Blood-Brain Barrier Permeability Prediction
ByAinvest
Monday, Aug 4, 2025 8:57 am ET1min read
LTRN--
Lantern Pharma has released an AI module, predictBBB.ai, which predicts blood-brain barrier permeability with 94% accuracy. This addresses a long-standing challenge in pharmaceutical development and establishes new benchmarks for computational drug discovery platforms. The technology leverages billions of molecular feature data points and real-time ensemble algorithm processing. The market for BBB technologies is projected to expand to $9.85 billion by 2032, making Lantern's solution a critical advancement in the field.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet